Changes in objectively measured physical activity after a multidisciplinary lifestyle intervention in children with abdominal obesity: a randomized control trial

Abstract

Background Physical activity (PA) is associated with changes in body composition that affect insulin sensitivity and leptin levels. Few studies have assessed the effect of lifestyle interventions on changes in objectively measured PA levels in obese children. To evaluate the effects of a multidisciplinary lifestyle intervention on anthropometric indices, biochemical parameters and accelerometer measured PA in abdominal obese children. Methods A randomized control trial was performed in 106 children and adolescents with abdominal obesity. Participants were randomly assigned to usual or intensive care group for 8-week. PA was measured by accelerometry over four days including, at least, two weekdays in all participants. Both groups were encouraged to accumulate an extra time of 200 min per week in their PA. Results At baseline, 75% of subjects do not fulfill the WHO recommendation of being more than 60 min/day on moderate-to-vigorous PA (MVPA). The intensive care group achieved a significant reduction in anthropometric indexes compared to the usual care but no significant change was found in biochemical or PA parameters. Both groups achieved a significant reduction in light PA. Interestingly, intensive care participants significantly increased MVPA in 5.5 min/day. Moreover, an inverse association between changes in MVPA and leptin levels was found. Conclusion The two lifestyle intervention reduced anthropometric indexes and lowered light PA in abdominal obese children. No significant differences were observed between intensive care and usual care in regard to PA. Intensive care participants significantly increase physical activity (MVPA) and, changes in MVPA were inversely associated with changes in leptin levels after the intervention. Trial registration ClinicalTrials.gov , Identifier: NCT03147261 . Registered 10 May 2017. Retrospectively registered. Electronic supplementary material The online version of this article (10.1186/s12887-019-1468-9) contains supplementary material, which is available to authorized users.

Melanocortin-4 Receptor and Lipocalin 2 Gene Variants in Spanish Children with Abdominal Obesity: Effects on BMI-SDS After a Lifestyle Intervention

“…Moderate-to-vigorous physical activity was assessed at baseline using triaxial accelerometry (Actigraph wGT3X-BT, Actigraph LLC, Penascola, FL, USA). Briefly, participants wore the accelerometer around the non-dominant waist for four days, including, at least, two weekend days, as described elsewhere [21]. Accelerometry data were analysed using ActiLife 6.0 software (Actigraph LLC, Penascola, FL, USA) as describe elsewhere [22].…”

Moxibustion combined with characteristic lifestyle intervention of Traditional Chinese Medicine in the treatment of abdominal obesity

“…In addition, lifestyle changes (exercise, diet control) can reduce anthropometric indexes in patients with abdominal obesity and these interventions are focused on improving fat consumption and metabolism capacity. [ 38 ] Also, moxibustion and lifestyle changes have many other advantages, including low-cost, stable efficacy, and low risks of complications. Although some studies confirmed such beneficial effects of moxibustion or lifestyle changes in improving abdominal obesity symptoms, the combined effects of moxibustion, and characteristic lifestyle intervention of TCM which includes lifestyle changes on abdominal obesity still remains unclear.…”

Higher Lipopolysaccharide Binding Protein and Chemerin Concentrations Were Associated with Metabolic Syndrome Features in Pediatric Subjects with Abdominal Obesity during a Lifestyle Intervention

“…The IGENOI study (Intervention of Grupo Estudio Navarro de Obesidad Infantil) is a randomized controlled trial (ClinicalTrials.gov, Identifier: NCT03147261) consisting of a 2-year outpatient program based on the Mediterranean diet, physical activity, and nutritional education [19][20][21]. Participants (aged 7 to 16 years) were recruited from the Paediatric Endocrinology Units at both Clínica Universidad de Navarra and Complejo Hospitalario de Navarra, in Pamplona, Navarra, Spain.…”